This review entitled “Innovations in the treatment of anaphylaxis: A review of recent data” explores innovative nasal and oral products under investigation for the outpatient emergency treatment of anaphylaxis.
Adrenaline auto-injectors (AAIs) are the current standard of first-line treatment for anaphylaxis, however, undercarriage and underuse of AAIs are common, and delayed use is associated with increased morbidity and mortality.
Read the full article at Annals of Allergy, Asthma & Immunology.
Enter your details below and we’ll email you our printable guide featuring the symptoms to look out for and what to do in an emergency.
You’ll also receive our monthly Allergy Outlook email with our latest news, updates and resources straight to your inbox.